Nomura Holdings’s bluebird bio BLUE Stock Holding History

Nomura Holdings’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-7,720	Closed	-$17.8M	–	1436
2017 Q4	$17.8M	Buy	+7,720	New	+$15.7M	0.03%	319

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nomura Holdings's BLUE Position: Q2 2019 in Review

Nomura Holdings sold out of bluebird bio (BLUE) in Q2 2019, closing a stake of 317 shares — an estimated $648K sold.

Nomura Holdings first reported a position in BLUE in Q3 2013 and held it in 4 quarters. The position peaked at $44.5M in Q4 2017. 273 funds tracked by Wall St. Rank hold BLUE as of Q2 2019.

Nomura Holdings reported no remaining bluebird bio position as of Q2 2019 after selling out during the quarter.
Nomura Holdings sold 317 bluebird bio shares in Q2 2019, an estimated $648K.
Nomura Holdings first reported a position in bluebird bio in Q3 2013 and held it in 4 quarters.
Nomura Holdings's bluebird bio position peaked at $44.5M in Q4 2017.
273 funds tracked by Wall St. Rank held bluebird bio as of Q2 2019.

Based on Nomura Holdings's 13F filing for Q2 2019, filed 14 Aug 2019.